APOC2 (Apolipoprotein C-II) Antibody, Biotin Conjugated, is a specialized immunoassay reagent designed to detect and quantify the APOC2 protein in biological samples. APOC2 is a 79–101 amino acid protein critical for lipid metabolism, primarily activating lipoprotein lipase to hydrolyze triglycerides . The biotin conjugation enables high-sensitivity detection through streptavidin-HRP or fluorescent streptavidin conjugates, facilitating applications like ELISA, Western blot (WB), and immunohistochemistry (IHC) .
Key characteristics include:
Host species: Primarily rabbit-derived polyclonal antibodies .
Clonality: Polyclonal formulations dominate, offering broad epitope recognition .
Immunogen: Typically recombinant human APOC2 fragments or peptides (e.g., residues 20–38 or Thr23-Glu101) .
Conjugate: Biotin linked via covalent bonding, ensuring stable binding to streptavidin .
Molecular Weight Variability: APOC2 is detected at 8–11 kDa across studies, likely due to post-translational processing or gel electrophoresis conditions .
Disease Relevance: APOC2 dysregulation links to cardiovascular diseases, amyloidosis, and lipid metabolism disorders .
Cross-Reactivity: Validated specificity for human APOC2, with no significant cross-reactivity to analogues reported .
Sensitivity: ELISA kits detect APOC2 concentrations as low as 0.5 µg/mL with inter-assay CV <12% .
Buffer Compatibility: Formulated in PBS with glycerol (50%) and sodium azide (0.02%) for long-term stability .
Biotinylation Efficiency: Validated via streptavidin-HRP binding in Western blots and ELISA .